PML is a potentially fatal brain infection, caused by the activation of the JC virus (JCV), which is present in approximately 55 percent of individuals with MS. The JCV remains dormant in most individuals, but may become active in people with weakened immune systems – such as those taking a strong immunosuppressant.
Read News ArticleSearch Results for:
Program Notes: MSAA’s New Aquatic Exercise Video
Posted on the Swim for MS online Aquatic Center, Introduction to MS Aquatic Fitness is MSAA’s latest educational video. This valuable resource demonstrates a wide variety of shallow-water exercises designed specifically for the MS community.
Read News ArticleThoughts about Giving: Sustaining Gifts
Thanks to our generous donors, Mary received a cooling vest through MSAA. Now she is able to enjoy going to her grandson’s baseball games and spend time in her garden. Tamara received a rolling walker that allows her to walk farther and with less fatigue, meaning she has been able to enjoy family trips for the first time in years.
Read News ArticleSpread the Word
Three books from MSAA’s free Lending Library are featured.
Read News ArticleOcrelizumab Shows Positive Results in Treating PPMS
Genentech announced today that ocrelizumab, an investigational medicine for the long-term treatment of relapsing forms of MS, has also shown positive study results in their Phase III ORATORIO study with primary-progressive multiple sclerosis (PPMS). This is the first medication to show positive effects on disability with this form of the disease, which affects approximately 10 percent of the MS population.
Read News ArticleElectronic Autoinjector Approved for Betaseron®
On September 25, 2015, the United States Food and Drug Administration (FDA) approved Betaconnect, an electronic autoinjector for use with Betaseron® (interferon beta-1b), an approved disease-modifying therapy (DMT) for the treatment of relapsing-remitting multiple sclerosis (RRMS). Although other autoinjectors are available to help with the administration of self-injected medications, this is the first electronic autoinjector to be approved by the FDA for a medication used in the long-term treatment of multiple sclerosis (MS).
Read News ArticleEmergency Preparedness Resources
In the event of a disaster in your area, make sure you can access emergency services.
Read News ArticleMy MS Manager™ Named One of the Best MS Mobile Apps of 2015 by Healthline
MSAA’s free mobile phone app, My MS Manager™ has been recognized as one of the top multiple sclerosis iPhone and Android apps of 2015 by Healthline.com. Healthline’s editors selected this year’s winners based on quality, usability, and contribution to the MS community.
Read News ArticleMSAA Wins 2015 Digital Health Award
MSAA’s My Health Insurance Guide was selected as a Merit Award winner in the 17th annual Digital Health Awards. This program honors the world’s best digital health resources.
My Health Insurance Guide is a dedicated section of MSAA’s website that provides comprehensive information on today’s health insurance topics specifically for the multiple sclerosis community.
Read News ArticleMultiple Sclerosis Coalition Applauds Passage of 21st Century Cures Act
The member organizations of the Multiple Sclerosis Coalition (MSC) congratulate the House on the passage of the 21st Century Cures Act – #Cures2015. The MSC specifically applauds the inclusion of H.R. 292 as a provision of the Act, the goal of which is to establish a data system to track the incidence and prevalence of neurological diseases, including multiple sclerosis.
Read News Article